IgE and high‐affinity IgE receptor in chronic inducible urticaria, pathogenic, and management relevance
Sign Up to like & getrecommendations! Published in 2022 at "Clinical and Translational Allergy"
DOI: 10.1002/clt2.12117
Abstract: Abstract Background IgE and high‐affinity IgE receptor (FcεRI) expression on basophils have been scarcely explored in patients with chronic inducible urticaria (CIndU). Objectives To investigate baseline serum IgE and FcεRI expression on blood basophils in… read more here.
Keywords: cindu; high affinity; expression; ige high ... See more keywords
Comparison between chronic spontaneous urticaria and chronic induced urticaria on the efficacy of omalizumab treatment: A systematic review and meta‐analysis
Sign Up to like & getrecommendations! Published in 2022 at "Dermatologic Therapy"
DOI: 10.1111/dth.15928
Abstract: This meta‐analysis aimed to assess the efficacy of omalizumab in the treatment of refractory‐to‐antihistamines chronic induced urticaria (CIndU) in comparison with that of refractory‐to‐antihistamines chronic spontaneous urticaria (CSU). We retrieved interventional studies and observational studies… read more here.
Keywords: cindu; meta analysis; efficacy; omalizumab treatment ... See more keywords
Unveiling Treatment Response Predictors in Predominant Subtypes of Chronic Inducible Urticaria
Sign Up to like & getrecommendations! Published in 2024 at "International Archives of Allergy and Immunology"
DOI: 10.1159/000536579
Abstract: Abstract Introduction: Chronic inducible urticaria (CIndU) is a subtype of chronic urticaria (CU), which requires specific triggers to occur. Despite their common occurrence, treatment response rates and predictors of treatment responses are largely lacking in… read more here.
Keywords: treatment; inducible urticaria; treatment response; response ... See more keywords